Hearing Preservation on Gentamicin Treatment for Meniere’s Disease
Meniere’s disease is characterized by episodic vertigo, fluctuating hearing loss, ear fullness and tinnitus. It may be due to increased pressure in one of the inner ear fluid compartments. Fluid in the inner ear chambers are constantly being produced and absorbed by the circulatory system. Any disturbance in this delicate relationship results in over-production or under-absorption of the fluids. This leads to increased fluid pressure (hydrops) that in turn produces dizziness which is often associated with fluctuating hearing loss and tinnitus. Endolymphatic hydrops is generally accepted as the histopathological finding for Meniere’s disease. However, pathophysiology of Meniere’s disease is still controversial.
KeywordsHearing Loss Hair Cell Outer Hair Cell Hearing Level Hearing Preservation
Unable to display preview. Download preview PDF.
- 1.Schuknecht HF (1957) Ablation therapy in the management of Meniere’s disease. Acta Otolaryngol (Stockh) 132: 3–42Google Scholar
- 4.Ödkvist LM, Berbenius J, Lundgen A (1984) Topical gentamicin treatment for disabling Meniere’s disease. Acta Otolaryngol Suppl (Stockh) 412: 74–76Google Scholar